Author

Hanqing Zhao

Observed name: Zhao, Hanqing

Institutions: Tianjin Medical University General Hospital, Tianjin Medical University

Observed institutions: Beijing Tongren Hospital, Tianjin Medical University General Hospital, Tongren Hospital, Fujian Provincial Hospital, First Affiliated Hospital of Zhengzhou University, Tianjin Medical University

OpenAlex ID: A5058366248

ANKRD29, as a new prognostic and immunological biomarker of non–small cell lung cancer, inhibits cell growth and migration by regulating MAPK signaling pathway

2023 · Hanqing Zhao, Yanbo Wang, et al. · Biology Direct · 8

Baicalin Inhibits Lung Cancer Cell Proliferation and Migration via ALOX12-Mediated Ferroptosis

2025 · Yishun Jin, JinYu Wen, et al. · Anti-Cancer Agents in Medicinal Chemistry · 5

Survival benefit of resection surgery for lung adenocarcinoma with bone metastases and a post-operative prognosis nomogram establishment and validation

2022 · Hanqing Zhao, Wenqi Li, et al. · Journal of Thoracic Disease · 2

IKZF4 acts as a novel tumor suppressor in non–small cell lung cancer by suppressing Notch signaling pathway

2023 · Yanbo Wang, Hanqing Zhao, et al. · Cellular Signalling · 1

Burden, trends and predictions of esophageal cancer in the top five GDP countries: a systematic analysis based on the Global Burden of Disease 2023 study

2026 · Hanqing Zhao, Zirong Wang, et al. · Journal of Thoracic Disease

Additional file 4 of ANKRD29, as a new prognostic and immunological biomarker of non–small cell lung cancer, inhibits cell growth and migration by regulating MAPK signaling pathway

2023 · Zhao, Hanqing, Wang, Yanbo, et al. · Figshare

Additional file 3 of ANKRD29, as a new prognostic and immunological biomarker of non–small cell lung cancer, inhibits cell growth and migration by regulating MAPK signaling pathway

2023 · Zhao, Hanqing, Wang, Yanbo, et al. · Figshare

Works count: 11

Citation count: 16

H-index: 2

I10-index: